Use of Stem Cell-Derived Cardiomyocyte and Nasal Epithelium Models to Establish a Multi-Tissue Model...
Use of Stem Cell-Derived Cardiomyocyte and Nasal Epithelium Models to Establish a Multi-Tissue Model Platform to Validate Repurposed Drugs Against SARS-CoV-2 Infection
About this item
Full title
Use of Stem Cell-Derived Cardiomyocyte and Nasal Epithelium Models to Establish a Multi-Tissue Model Platform to Validate Repurposed Drugs Against SARS-CoV-2 Infection
Publisher
NewsRX LLC
Journal title
Stem cell week, 2024-06, p.42
Language
English
Formats
Publication information
Publisher
NewsRX LLC
Subjects
More information
Alternative Titles
Full title
Use of Stem Cell-Derived Cardiomyocyte and Nasal Epithelium Models to Establish a Multi-Tissue Model Platform to Validate Repurposed Drugs Against SARS-CoV-2 Infection
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_gale_infotracmisc_A796989961
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A796989961
Other Identifiers
ISSN
1537-1360
How to access this item
Log in as a Library member
